Pharmacoeconomic Evaluation on the Literature of Aripiprazol vs.Risperidone in the Treatment of Schizophrenia
- VernacularTitle:阿立哌唑与利培酮治疗精神分裂症文献的经济学评价
- Author:
Jianqing TAO
;
Jiabin LIU
;
Xuebing YIN
;
Xiafang WU
- Publication Type:Journal Article
- Keywords:
Aripiprazole;
Risperidone;
Schizophrenia;
Meta-analysis;
Cost minimization analysis
- From:
China Pharmacy
2007;0(29):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).CONCLUSION: There is no pharmacoeconomic difference between aripiprazol and risperidone in the treatment schizophrenia.
